Published in Atherosclerosis on February 01, 2005
Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2011) 5.30
Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis. CMAJ (2011) 2.40
Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol (2012) 1.76
Update on statin-mediated anti-inflammatory activities in atherosclerosis. Semin Immunopathol (2009) 1.04
Impact of exercise training on arterial wall thickness in humans. Clin Sci (Lond) (2012) 1.00
National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool. Ther Clin Risk Manag (2013) 0.93
Nonalcoholic fatty liver disease and the heart in children and adolescents. World J Gastroenterol (2014) 0.83
Combined effects of aerobic exercise and diet on lipids and lipoproteins in overweight and obese adults: a meta-analysis. J Obes (2012) 0.79
Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques. Cardiovasc Diabetol (2016) 0.78
Causes of changes in carotid intima-media thickness: a literature review. Cardiovasc Ultrasound (2015) 0.77
Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled Trials. Chin Med J (Engl) (2016) 0.76
Should a statin be prescribed to every patient with heart failure? Heart Fail Rev (2007) 0.76
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA (2005) 12.00
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med (2008) 10.03
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet (2003) 4.19
Comprehensive warm-up programme to prevent injuries in young female footballers: cluster randomised controlled trial. BMJ (2008) 3.71
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction. Circulation (2011) 3.38
Risk factors for injuries in football. Am J Sports Med (2004) 2.66
Exercises to prevent lower limb injuries in youth sports: cluster randomised controlled trial. BMJ (2005) 2.55
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. J Am Coll Cardiol (2008) 2.51
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation (2008) 2.30
Urban air pollution and mortality in a cohort of Norwegian men. Environ Health Perspect (2004) 2.26
Exposure therapy and sertraline in social phobia: I-year follow-up of a randomised controlled trial. Br J Psychiatry (2003) 2.21
Accelerometer-determined physical activity in adults and older people. Med Sci Sports Exerc (2012) 2.06
Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial. J Am Coll Cardiol (2009) 1.97
Rosuvastatin in diabetic hemodialysis patients. J Am Soc Nephrol (2011) 1.85
Intrinsic risk factors for hamstring injuries among male soccer players: a prospective cohort study. Am J Sports Med (2010) 1.73
Helmet use and risk of head injuries in alpine skiers and snowboarders. JAMA (2006) 1.67
Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study. Eur J Endocrinol (2011) 1.49
Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels. Int J Cardiol (2013) 1.49
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med (2004) 1.43
Trends in the incidence of acute myocardial infarction and stroke: a 21-year follow-up of the Oslo study. Scand Cardiovasc J (2004) 1.42
Compliance with a comprehensive warm-up programme to prevent injuries in youth football. Br J Sports Med (2010) 1.25
Prevention of injuries among male soccer players: a prospective, randomized intervention study targeting players with previous injuries or reduced function. Am J Sports Med (2008) 1.21
Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis. Clin J Am Soc Nephrol (2011) 1.19
Promoting physical activity in a low-income multiethnic district: effects of a community intervention study to reduce risk factors for type 2 diabetes and cardiovascular disease: a community intervention reducing inactivity. Diabetes Care (2006) 1.15
Physical fitness, injuries, and team performance in soccer. Med Sci Sports Exerc (2004) 1.14
Effect of playing tactics on achieving score-box possessions in a random series of team possessions from Norwegian professional soccer matches. J Sports Sci (2010) 1.14
Low back pain among endurance athletes with and without specific back loading--a cross-sectional survey of cross-country skiers, rowers, orienteerers, and nonathletic controls. Spine (Phila Pa 1976) (2004) 1.13
Risk factors for injuries in alpine skiing, telemark skiing and snowboarding--case-control study. Br J Sports Med (2011) 1.10
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. Am J Cardiol (2007) 1.09
Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic. Ann Rheum Dis (2012) 1.06
Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease. Am J Cardiol (2009) 1.04
Risk factors for lower extremity injuries in elite female soccer players. Am J Sports Med (2014) 1.02
Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease. Arthritis Rheum (2012) 1.00
Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr (2005) 1.00
Effect of playing tactics on goal scoring in Norwegian professional soccer. J Sports Sci (2010) 1.00
Inflammation in renal transplantation. Clin J Am Soc Nephrol (2009) 0.99
Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients. Kidney Int (2010) 0.98
Predictiveness of body mass index for fatal coronary heart disease in men according to length of follow-up: a 21-year prospective cohort study. Scand J Public Health (2007) 0.98
Patterns of objectively measured physical activity in normal weight, overweight, and obese individuals (20-85 years): a cross-sectional study. PLoS One (2013) 0.95
Secular trends in adiposity in Norwegian 9-year-olds from 1999-2000 to 2005. BMC Public Health (2009) 0.95
Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil (2006) 0.94
6-year follow-up of 84 patients with cartilage defects in the knee. Knee scores improved but recovery was incomplete. Acta Orthop (2010) 0.93
Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease. Am J Cardiol (2007) 0.93
Intrinsic risk factors for groin injuries among male soccer players: a prospective cohort study. Am J Sports Med (2010) 0.92
Inflammation-associated graft loss in renal transplant recipients. Nephrol Dial Transplant (2011) 0.92
Promoting physical activity in a multi-ethnic district - methods and baseline results of a pseudo-experimental intervention study. Eur J Cardiovasc Prev Rehabil (2003) 0.91
Validity of the ActiGraph GT1M during walking and cycling. J Sports Sci (2013) 0.90
Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population. Ann Med (2011) 0.90
Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction? Am J Cardiol (2006) 0.89
Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial. Rheumatology (Oxford) (2010) 0.89
Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study. Arthritis Rheum (2009) 0.88
Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation (2015) 0.88
fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study. Am J Transplant (2004) 0.88
Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study. Am J Nephrol (2013) 0.87
The prevalence of low back pain among former elite cross-country skiers, rowers, orienteerers, and nonathletes: a 10-year cohort study. Am J Sports Med (2012) 0.87
The "Romsås in Motion" community intervention: program exposure and psychosocial mediated relationships to change in stages of change in physical activity. Int J Behav Nutr Phys Act (2007) 0.87
Weight cycling and risk of forearm fractures: a 28-year follow-up of men in the Oslo Study. Am J Epidemiol (2008) 0.87
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. Kidney Int (2004) 0.87
The external validation of the cardiovascular risk equation for renal transplant recipients: applications to BENEFIT and BENEFIT-EXT trials. Transplantation (2013) 0.86
Markers of inflammation are inversely related to physical activity and fitness in sedentary men with treated hypertension. Am J Hypertens (2006) 0.86
Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease. Atherosclerosis (2002) 0.86
Intervention effects on physical activity and insulin levels in men of Pakistani origin living in Oslo: a randomised controlled trial. J Immigr Minor Health (2013) 0.84
Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease. Thromb Res (2002) 0.84
The "Romsås in Motion" community intervention: mediating effects of psychosocial factors on forward transition in the stages of change in physical activity. Health Educ Behav (2007) 0.83
Correlates of objectively measured physical activity in adults and older people: a cross-sectional study of population-based sample of adults and older people living in Norway. Int J Public Health (2013) 0.82
Cerebrovascular events in renal transplant recipients. Transplantation (2009) 0.82
Preventing eating disorders among young elite athletes: a randomized controlled trial. Med Sci Sports Exerc (2014) 0.81
A cardiovascular risk calculator for renal transplant recipients. Transplantation (2012) 0.81
Cartilage repair in the rabbit knee: mosaic plasty resulted in higher degree of tissue filling but affected subchondral bone more than microfracture technique: a blinded, randomized, controlled, long-term follow-up trial in 88 knees. Knee Surg Sports Traumatol Arthrosc (2011) 0.81
Great Health Benefits But No Change in Employment or Psychopharmaceutical Drug Use 2 Years After Roux-en-Y Gastric Bypass. Obes Surg (2015) 0.81
Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction. Am J Cardiol (2009) 0.80
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study). Am J Cardiol (2010) 0.79
Dietary and antismoking advice and ischemic heart disease mortality in men with normal or high fasting triacylglycerol concentrations: a 23-y follow-up study. Am J Clin Nutr (2003) 0.79
Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations. Metab Syndr Relat Disord (2012) 0.79
Self-reported injury history and lower limb function as risk factors for injuries in female youth soccer. Am J Sports Med (2008) 0.78
One- and five-year follow-ups on blood pressure and renal function in kidney donors. Transpl Int (2010) 0.78
A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-year-old men and women. J Cardiovasc Risk (2003) 0.78
Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study. Am J Cardiol (2004) 0.78
Dianicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial. Nicotine Tob Res (2010) 0.78
Effect of lifestyle and/or statin treatment on soluble markers of atherosclerosis in hypertensives. Scand Cardiovasc J (2007) 0.78
Validity and reliability of the 20 meter shuttle run test in military personnel. Mil Med (2011) 0.77
[Changes in cardiovascular risk factors among men in Oslo during 28 years]. Tidsskr Nor Laegeforen (2006) 0.77
Prediction of cardiovascular events in patients with ankylosing spondylitis and psoriatic arthritis: role of lipoproteins in a high-risk population. J Rheumatol (2012) 0.77
Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients. Clin Transplant (2013) 0.76
LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study. Eur J Cardiovasc Prev Rehabil (2011) 0.76
The Vertical Drop Jump Is a Poor Screening Test for ACL Injuries: Response. Am J Sports Med (2016) 0.76
Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients. Transplantation (2014) 0.76
Comment on Schiøtz et al.: Ten-year follow-up after conservative treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.75
[Cardiovascular risk factors among 40-year old men and women in Oslo 1981-1999]. Tidsskr Nor Laegeforen (2004) 0.75
On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study. Eur J Clin Invest (2010) 0.75
Associations between type A behaviour pattern and psychological distress : 28 years of follow-up of the Oslo Study 1972/1973. Soc Psychiatry Psychiatr Epidemiol (2007) 0.75
Risk-factor profile for the incidence of subarachnoid and intracerebral haemorrhage, cerebral infarction, and unspecified stroke during 21 years' follow-up in men. Scand J Public Health (2006) 0.75
Uric acid and clinical correlates of endothelial function in kidney transplant recipients. Clin Transplant (2014) 0.75
The development of the brief eating disorder in athletes questionnaire. Med Sci Sports Exerc (2014) 0.75